1 |
SHEHAB N, PATEL P R, SRINIVASAN A, et al.. Emergency department visits for antibiotic-associated adverse events[J]. Clin. Infect. Dis., 2008, 47(6): 735-743.
|
2 |
AMLEROVA J, ŠROUBEK J, ANGELUCCI F, et al.. Evidences for a role of gut microbiota in pathogenesis and management of epilepsy[J/OL]. Int. J. Mol. Sci., 2021, 22(11): 5576[2022-12-16]. .
|
3 |
SHEIKH S, ALVI U, SOLIVEN B, et al.. Drugs that induce or cause deterioration of myasthenia gravis: an update[J/OL]. J. Clin. Med., 2021, 10(7): 10071537[2022-12-16]. .
|
4 |
WALKER A E, JOHNSON H C. Principles and practice of penicillin therapy in diseases of the nervous system[J]. Ann. Surg., 1945, 122(6): 1125-1135.
|
5 |
BHATTACHARYYA S, DARBY R R, RAIBAGKAR P, et al.. Antibiotic-associated encephalopathy[J]. Neurology, 2016, 86(10): 963-971.
|
6 |
FAN H, GILBERT R, O'CALLAGHAN F, et al.. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study[J/OL]. BMJ Res., 2020, 368: m331[2023-02-09]. .
|
7 |
CHOW K M, HUI A C, SZETO C C. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside[J]. Eur. J. Clin. Microbiol. Infect. Dis., 2005, 24(10): 649-653.
|
8 |
VAN DONGE T, FUCHS A, LEROUX S, et al.. Amoxicillin dosing regimens for the treatment of neonatal sepsis: balancing efficacy and neurotoxicity[J]. Neonatology, 2020, 117(5): 619-627.
|
9 |
ING C, MA X, SUN M, et al.. Exposure to surgery and anesthesia in early childhood and subsequent use of attention deficit hyperactivity disorder medications[J]. Anesth. Analg., 2020, 131(3): 723-733.
|
10 |
ATLI O, DEMIR-OZKAY U, ILGIN S, et al.. Evidence for neurotoxicity associated with amoxicillin in juvenile rats[J]. Hum. Exp. Toxicol., 2016, 35(8): 866-876.
|
11 |
SOMOZA-CANO F J, ARMASHI A R, WEILAND A, et al.. Cefepime-induced delirium[J/OL]. Cureus, 2021, 13(6): e15505[2021-07-16]. .
|
12 |
LIM R, HONG L, TAN L F, et al.. Cephalosporin-related neurotoxicity[J/OL]. Age Age., 2021, 50(1): 267[2023-02-09]. .
|
13 |
KEERTY D, SHAREEF N A, RAMSAKAL A, et al.. Cefepime-induced encephalopathy[J/OL]. Cureus, 2021, 13(2): e13125[2021-02-04]. .
|
14 |
FU X, WAN P, LI P, et al.. Mechanism and prevention of ototoxicity induced by aminoglycosides[J/OL]. Front Cell Neurosci., 2021, 15: 692762[2023-02-09]. .
|
15 |
BISCHOFF A, MEIER C, ROTH F. Gentamicin neurotoxicity (polyneuropathy-encephalopathy)[J]. Schweiz. Med. Wochenschr., 1977, 107(1): 3-8.
|
16 |
SHAEER K M, ZMARLICKA M T, CHAHINE E B, et al.. Plazomicin: a next-generation aminoglycoside[J]. Pharmacotherapy, 2019, 39(1): 77-93.
|
17 |
KASS J S, SHANDERA W X. Nervous system effects of antituberculosis therapy[J]. CNS Drug., 2010, 24(8): 655-667.
|